Dose of Inhaled Corticosteroid in Chronic Obstructive Pulmonary Disease and Risks of Osteoporosis or Fracture—A Systematic Review and Meta‐Analysis
ABSTRACT Background Inhaled corticosteroid (ICS) is a major pharmacotherapy for chronic obstructive pulmonary disease (COPD), which is associated with various adverse effects. Controversies exist in whether ICS use in COPD is associated with osteoporosis or fracture. Objective We performed a systema...
Saved in:
| Main Authors: | Wang Chun Kwok, Chung Ki Tsui, Sze Him Isaac Leung, Shuk Man Ngai, David Chi Leung Lam, Mary Sau Man Ip, James Chung Man Ho |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2025-05-01
|
| Series: | The Clinical Respiratory Journal |
| Subjects: | |
| Online Access: | https://doi.org/10.1111/crj.70086 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Elevated Fracture Risks in Patients Using Inhaled Corticosteroids: A Korean Nationwide Study
by: Sung Hye Kong, et al.
Published: (2025-02-01) -
Osteoporosis Awareness in Asthma Patients Using Inhaled Corticosteroids: A Cross-Sectional Study
by: Sevda Cömert, et al.
Published: (2025-06-01) -
Evaluating inhaled corticosteroids' impact on osteoporosis and fracture risk in COPD patients: a real-world evidence-based systematic review and meta-analysis
by: Hsiao-Feng Huang, et al.
Published: (2025-06-01) -
Inhaled corticosteroids in asthma and chronic obstructive pulmonary disease combined phenotype: when to use and what to expect?
by: Srishankar Bairy, et al.
Published: (2025-01-01) -
Oral health status of asthmatic children using inhaled corticosteroids
by: Münevver Doğan, et al.
Published: (2021-02-01)